BIO Stock 12 Month Analyst Forecast
Eps Overview
Growth Next 5yrs
5.16%
Last Quarter
$2.26
Past Year
- $24.30
Growth Past 5yrs
N/A
Next Quarter
$2.71
Estimate Next Year
$0.99
Consensus Rating
Loading...
Consensus Price Target
Highest Price Target
$409.00
33.7% Upside
Mean Price Target
$327.00
6.9% Upside
Lowest Price Target
$245.00
-19.91% Downside
Recent Analyst Ratings
Upgrades, Downgrades, New Coverage
Actual EPS vs Estimated EPS
BIO Earnings Per Share (EPS) History
According to financial reports, BIO (NYSE: BIO) reported an actual EPS of $2.26 for the quarter ending on Oct 29, 2025, compared to an estimated $2.3, resulting in a -1.74% surprise. In the prior quarter (Jul 31, 2025), BIO recorded an actual EPS of $2.61 with a 35.23% surprise. See BIO's full earnings history.
Earnings History
EPS Surprise Factor Analysis
BIO has experienced notable EPS surprises, with the latest quarter ending Oct 29, 2025 showing a -1.74% miss. Previously, the quarter ending Jul 31, 2025 recorded a 35.23% beat. An EPS surprise factor indicates how much actual earnings deviate from analyst forecasts.
| Report Date | Actual | Forecast | Surprise Factor |
|---|---|---|---|
| Oct 29, 2025 | 2.26 | 2.3 | -1.74% |
| Jul 31, 2025 | 2.61 | 1.93 | +35.23% |
| May 01, 2025 | 2.54 | 1.73 | +46.82% |
| Feb 13, 2025 | 2.9 | 2.86 | +1.40% |
| Oct 30, 2024 | 23.09 | 1.16 | +1,890.52% |
| Aug 01, 2024 | -76.26293 | 2.12 | -3,697.31% |
Frequently Asked Questions
Is BIO stock getting favorable reviews from Wall Street analysts?
Brokerage firms have given BIO stock an average recommendation of
Buy. 7 analysts have given their ratings
to BIO out of which
1 analysts have given strong buy call,
2 analysts have given buy call,
4 analysts rate it hold,
0 analysts advocate strong sell call, and
0 analysts has given sell rating. The average target price of
$327.00 gives the stock implied upside
of roughly 6.9% over the next year or so.
What have analysts suggested for BIO highest price target?
Analysts suggest BIO's stock price would rise to a high of $409.00.
What is the lowest price target analysts expect for BIO over the next year?
Within the next 12 months, analysts predict the BIO stock price could move to $245.00.
What is the average target price for BIO?
BIO stock has an average analyst estimate of $327.00.
At its current price, how far is BIO from its average target price?
BIO shares are currently trading 6.9% above this price target.
What were BIO’s actual earnings per share for the recent quarter?
Its quarterly earnings per share (EPS) came in at $2.26 versus consensus estimates of $2.30, and below the comparable year-ago quarter’s EPS of $23.09.
What are the current estimates for quarterly and annual earnings per share?
BIO's forecasts by analysts estimating quarterly EPS at $2.71 and $0.99 for the whole year.
What has BIO's growth been in the past five years and what is expected in the next five years?
The analysts have projected 5.16% EPS growth for BIO in the next five years, compared to growth rates of N/A in the past five years.